Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion type Assertion NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_head.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion description "[In particular, the paper takes into account DNA content, cell-cycle and apoptosis-regulatory proteins, epidermal growth factor receptor [EGFR], vascular endothelial growth factor [VEGF], cyclooxygenase [COX]-2, signal transducer and activator of transcription [Stat]3, human papilloma virus [HPV] status, tumor hypoxia, tumor infiltrating lymphocytes [TIL], microarray technology and microRNA (miRNA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_provenance.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion evidence source_evidence_literature NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_provenance.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion SIO_000772 23031678 NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_provenance.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion wasDerivedFrom befree-2016 NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_provenance.
- NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_assertion wasGeneratedBy ECO_0000203 NP1017684.RAFQmM9FucC7X-upZT3-a2xW3jQlyhIOyXS0Hcg9-TaKY130_provenance.